nat4900
Diamond Member
- Mar 3, 2015
- 42,021
- 5,965
There's little doubt that the TPP is one of the last nails in this country's industrial-belt's coffin.
Among the many provisions within the TPP the issue of "patent protection" is a double-edged sword. It seems fair that a patent should be respected and that compensation to the patent owner should be honored.....and that would be true except in one particular area; an area that because of the TTP will cost lives not only here but throughout the planet while making a few individuals ultra rich.....That area is the drug manufacturing industry.
In most developing countries, drugs are far cheaper than in the United States. This is especially the case in India. The country has a world-class generic industry that produces high-quality drugs that typically sell for a small fraction of the price in the United States. For example, the generic version of the Hepatitis C drug Sovaldi can be purchased in India for less than $1,000 a treatment. The patent protected version sells in the United States for $84,000. The TPP Drug Patents and President Clinton Dean Baker
For the "legacy" that he may gain (infamy, really) shame on Obama for embracing lobbyists and forsaking his friends and previous partners.
Among the many provisions within the TPP the issue of "patent protection" is a double-edged sword. It seems fair that a patent should be respected and that compensation to the patent owner should be honored.....and that would be true except in one particular area; an area that because of the TTP will cost lives not only here but throughout the planet while making a few individuals ultra rich.....That area is the drug manufacturing industry.
In most developing countries, drugs are far cheaper than in the United States. This is especially the case in India. The country has a world-class generic industry that produces high-quality drugs that typically sell for a small fraction of the price in the United States. For example, the generic version of the Hepatitis C drug Sovaldi can be purchased in India for less than $1,000 a treatment. The patent protected version sells in the United States for $84,000. The TPP Drug Patents and President Clinton Dean Baker
For the "legacy" that he may gain (infamy, really) shame on Obama for embracing lobbyists and forsaking his friends and previous partners.